New drug combo may outperform chemo for returning ovarian cancer
NCT ID NCT02446600
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study tests whether olaparib (a targeted drug) alone or combined with cediranib (which blocks tumor blood vessels) works better than standard platinum chemo for women whose ovarian, fallopian tube, or peritoneal cancer has returned after initial treatment. About 579 participants with platinum-sensitive cancer are enrolled. The main goal is to see how long the cancer stays under control before growing again.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
579 people
The number who actually took part.
- Started
-
Mar 2016
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients must have platinum-sensitive recurrent high-grade serous or high-grade endometrioid ovarian, primary peritoneal, or fallopian tube cancers; patients with other (clear cell, mixed epithelial, undifferentiated carcinoma, or transitional cell carcinoma) high-risk histologies are also eligible, provided that the patient has a known deleterious germline BRCA1 or BRCA2 mutation identified through testing at a clinical laboratory; Note: Due to the long acceptance of germline BRCA testing through Myriad, Myriad testing will be accepted; if testing for germline BRCA is done by other organizations, documentation from a qualified medical professional (e.g., ovarian cancer specialty physician involved in the field, high risk genetics physician, genetics counselor) listing the mutation and confirming that the laboratory results showed a recognized germline deleterious BRCA1 or BRCA2 mutation or BRCA rearrangement is required; please collect a copy of Myriad or other BRCA mutational analysis (positive or VUS or negative) reports * Platinum-sensitive disease defined as no clinical or radiographic evidence of disease recurrence for \> 6 months (or 182 days) after last receipt of platinum-based therapy * Patients must have had a complete clinical response to their prior line of platinum therapy and cannot have had progression through prior platinum-based therapy * Patients must have signed an approved informed consent and authorization permitting release of personal health information * Patients must have evaluable disease - defined as one of the following: * Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 measurable disease OR * Evaluable disease (defined as solid and/or cystic abnormalities on radiographic imaging that do not meet RECIST 1.1 definitions for target lesions OR ascites and/or pleural effusion that has been pathologically demonstrated to be disease-related) AND a cancer antigen 125 (CA125) that has doubled from the post-treatment nadir and is also greater than 2 times upper limit of normal (ULN) * Prior therapy: * Prior chemotherapy must have included a first-line platinum-based regimen with or without intravenous consolidation chemotherapy * Patients may have received an unlimited number of platinum-based therapies in the recurrent setting * Patients may have received up to 1 non-platinum-based line of therapy in the recurrent setting; prior hormonal therapy will not be considered to count as this non-platinum-based line * Patients may not have had a prior anti-angiogenic agent in the recurrent setting; prior use of bevacizumab in the upfront or upfront maintenance setting is allowed * Patients may not have previously received a poly adenosine diphosphate (ADP) ribose polymerase (PARP)-inhibitor * Prior hormonal-based therapy for ovarian, primary peritoneal, or fallopian tube cancer is acceptable * Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 (Karnofsky \>= 60%) * Absolute neutrophil count \>= 1,500/mcL * Platelets \>= 100,000/mcL * Hemoglobin \>= 10 g/dL * Creatinine =\< the institutional upper limit of normal (ULN) OR creatinine clearance \>= 60 mL/min/1.73 m\^2 for patients with creatinine levels above institutional normal * Urine protein: creatinine ratio (UPC) of =\< 1 or less than or equal to 2+ proteinuria on two consecutive dipsticks taken no less than 1 week apart; UPC is the preferred test; patients with \>= 2+ proteinuria on dipstick must also have a 24 hour urine collection demonstrating =\< 500 mg over 24 hours * Total bilirubin =\< 1.5 x the institutional ULN * Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase \[SGOT\]) and alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase \[SGPT\]) =\< 3 times institutional ULN * Toxicities of prior therapy (excepting alopecia) should be resolved to less than or equal to grade 1 as per National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE); patients with long-standing stable grade 2 neuropathy may be considered after discussion with the overall principal investigator (PI), but may not receive carboplatin and paclitaxel as the reference regimen, if randomized to that arm * Patients must be able to swallow and retain oral medications and without gastrointestinal illnesses that would preclude absorption of cediranib or olaparib * Patients must have adequately controlled blood pressure (BP), with a BP no greater than 140 mmHg (systolic) and 90 mmHg (diastolic) for eligibility; patients must have a BP of =\< 140/90 mmHg taken in the clinic setting by a medical professional within 2 weeks prior to starting study; patients with hypertension may be managed with up to a maximum of three antihypertensive medications; it is strongly recommended that patients who are on three antihypertensive medications be followed by a cardiologist or blood pressure specialist for management of blood pressure while on protocol * Patients must be willing and able to check and record daily blood pressure readings; blood pressure cuffs will be provided to patients randomized to Arm III * Cediranib has been shown to terminate fetal development in the rat, as expected for a process dependent on VEGF signaling; for this reason, women of child-bearing potential must have a negative pregnancy test prior to study entry; women of child-bearing potential must agree to use two reliable forms of contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 6 weeks after cediranib discontinuation; should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately * Adequately controlled thyroid function, with no symptoms of thyroid dysfunction and thyroid stimulating hormone (TSH) within normal limits * Age \>= 18 Exclusion Criteria: * Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) of starting treatment or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier; patients may not have had hormonal therapy within 2 weeks prior to entering the study; patients receiving raloxifene for bone health as per Food and Drug Administration (FDA) indication may remain on raloxifene absent other drug interactions * Patients may not be receiving any other investigational agents nor have participated in an investigational trial within the past 4 weeks * Patients may not be receiving any medication that may markedly affect renal function (e.g., vancomycin, amphotericin, pentamidine) * Patients may not have received prior treatment affecting the vascular endothelial growth factor (VEGF) pathway (including, but not limited to thalidomide, sunitinib, pazopanib, sorafenib, and nintedanib); bevacizumab used in the upfront setting in conjunction with chemotherapy and/or as maintenance to treat newly diagnosed disease will be allowed * Patients may not have previously received a PARP inhibitor * CA-125 only disease without RECIST 1.1 measurable or otherwise evaluable disease * Patients with untreated brain metastases, spinal cord compression, or evidence of symptomatic brain metastases or leptomeningeal disease as noted on CT or MRI scans should not be included on this study, since neurologic dysfunction may confound the evaluation of neurologic and other adverse events; screening imaging to rule out brain metastases is not required for screening, but should be performed prior to study enrollment if clinically indicated; patients with treated brain metastases and resolution of any associated symptoms must demonstrate stable post-therapeutic imaging for at least 6 months following therapy prior to starting study drug * History of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib or olaparib * Participants receiving any medications or substances that are strong inhibitors or inducers of cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) are ineligible; strong inhibitors and inducers of UGT/PgP should be used with caution * History of gastrointestinal perforation; patients with a history of abdominal fistula will be considered eligible if the fistula was surgically repaired or has healed, there has been no evidence of fistula for at least 6 months, and patient is deemed to be at low risk of recurrent fistula * History of intra-abdominal abscess within the past 3 months * Current signs and/or symptoms of bowel obstruction or signs and/or symptoms of bowel obstruction within 3 months prior to starting study drugs * Dependency on intravenous (IV) hydration or total parenteral nutrition (TPN) * Any concomitant or prior invasive malignancies with the following curatively treated exceptions: * Treated limited stage basal cell or squamous cell carcinoma of the skin * Carcinoma in situ of the breast or cervix * Primary endometrial cancer meeting the following conditions: stage not greater than IA, grade 1 or 2, no more than superficial myometrial invasion, without vascular or lymphatic invasion; no poorly differentiated subtypes, including papillary serous/serous, clear cell, or other International Federation of Gynecology and Obstetrics (FIGO) grade 3 lesions * Prior cancer treated with a curative intent with no evidence of recurrent disease 3 years following diagnosis and judged by the investigator to be at low risk of recurrence * Patients with any of the following: * History of myocardial infarction within six months * Unstable angina * Resting electrocardiogram (ECG) with clinically significant abnormal findings * New York Heart Association (NYHA) classification of III or IV * If cardiac function assessment is clinically indicated or performed: left ventricular ejection fraction (LVEF) less than normal per institutional guidelines, or \< 55%, if threshold for normal not otherwise specified by institutional guidelines * Patients with the following risk factors should have a baseline cardiac function assessment: * Prior treatment with anthracyclines * Prior treatment with trastuzumab * Prior central thoracic radiation therapy (RT), including RT to the heart * History of myocardial infarction within 6 to 12 months (patients with history of myocardial infarction within 6 months are excluded from the study) * Prior history of impaired cardiac function * History of stroke or transient ischemic attack within six months * Any prior history of hypertensive crisis or hypertensive encephalopathy * Clinically significant peripheral vascular disease or vascular disease (including aortic aneurysm or aortic dissection) * Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to starting cediranib * Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia (other than atrial fibrillation with controlled ventricular rate), or psychiatric illness/social situations that would limit compliance with study requirements * Pregnant women are excluded from this study because cediranib and olaparib are agents with the potential for teratogenic or abortifacient effects; because there is an unknown but potential risk of adverse events in nursing infants secondary to treatment of the mother with cediranib and olaparib, breastfeeding should be discontinued if the mother is treated with cediranib or olaparib; these potential risks may also apply to other agents used in this study * Known HIV-positive individuals are ineligible because of the potential for pharmacokinetic interactions with cediranib or olaparib; in addition, these individuals are at increased risk of lethal infections when treated with marrow-suppressive therapy * Patients may not use any complementary or alternative medicines including natural herbal products or folk remedies as they may interfere with the effectiveness of the study treatments * No features suggestive of myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) on peripheral blood smear or bone marrow biopsy, if clinically indicated * No prior allogeneic bone marrow transplant or double umbilical cord blood transplantation (dUBCT)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fallopian tube clear cell adenocarcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abbott-Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
-
Adams Cancer Center
Gettysburg, Pennsylvania, 17325, United States
-
Advocate Lutheran General Hospital
Park Ridge, Illinois, 60068, United States
-
Alaska Women's Cancer Care
Anchorage, Alaska, 99508, United States
-
Alegent Health Bergan Mercy Medical Center
Omaha, Nebraska, 68124, United States
-
Alegent Health Lakeside Hospital
Omaha, Nebraska, 68130, United States
-
Algoma District Cancer Program Sault Area Hospital
Sault Ste. Marie, Ontario, P6B 0A8, Canada
-
AnMed Health Cancer Center
Anderson, South Carolina, 29621, United States
-
Arizona Oncology Associates-West Orange Grove
Tucson, Arizona, 85704, United States
-
Arizona Oncology Associates-Wilmot
Tucson, Arizona, 85710, United States
-
Arthur J E Child Comprehensive Cancer Centre
Calgary, Alberta, T2N 5G2, Canada
-
Ascension Saint Vincent Indianapolis Hospital
Indianapolis, Indiana, 46260, United States
-
Ascension Via Christi Hospitals Wichita
Wichita, Kansas, 67214, United States
-
Aspirus Cancer Care - Stevens Point
Stevens Point, Wisconsin, 54481, United States
-
Associates In Womens Health
Wichita, Kansas, 67208, United States
-
Atrium Health Navicent
Macon, Georgia, 31201, United States
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Ballad Health Cancer Care - Kingsport
Kingsport, Tennessee, 37660, United States
-
Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
-
Beebe Health Campus
Rehoboth Beach, Delaware, 19971, United States
-
Benefis Sletten Cancer Institute
Great Falls, Montana, 59405, United States
-
Billings Clinic Cancer Center
Billings, Montana, 59101, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
CHI Health Good Samaritan
Kearney, Nebraska, 68847, United States
-
CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
Québec, Quebec, G1R 2J6, Canada
-
CHUM - Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, H2X 3E4, Canada
-
CIUSSSEMTL-Hopital Maisonneuve-Rosemont
Montreal, Quebec, H1T 2M4, Canada
-
California Pacific Medical Center-Pacific Campus
San Francisco, California, 94115, United States
-
Cancer Care Center of O'Fallon
O'Fallon, Illinois, 62269, United States
-
Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, 62526, United States
-
Case Western Reserve University
Cleveland, Ohio, 44106, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Centralia Oncology Clinic
Centralia, Illinois, 62801, United States
-
Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, J1H 5N4, Canada
-
Christiana Care Health System-Christiana Hospital
Newark, Delaware, 19718, United States
-
Cleveland Clinic Akron General
Akron, Ohio, 44307, United States
-
Cleveland Clinic Cancer Center/Fairview Hospital
Cleveland, Ohio, 44111, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Columbus Oncology and Hematology Associates Inc
Columbus, Ohio, 43214, United States
-
Community Medical Center
Missoula, Montana, 59804, United States
-
Cooper Hospital University Medical Center
Camden, New Jersey, 08103, United States
-
Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Grand Rapids, Michigan, 49503, United States
-
Cotton O'Neil Cancer Center / Stormont Vail Health
Topeka, Kansas, 66606, United States
-
Covenant Health Cancer Centers
Knoxville, Tennessee, 37916, United States
-
Covenant Health Cancer Centers - West
Knoxville, Tennessee, 37932, United States
-
CoxHealth South Hospital
Springfield, Missouri, 65807, United States
-
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
-
Crossroads Cancer Center
Effingham, Illinois, 62401, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Dartmouth Cancer Center - Nashua
Nashua, New Hampshire, 03063, United States
-
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Lebanon, New Hampshire, 03756, United States
-
Decatur Memorial Hospital
Decatur, Illinois, 62526, United States
-
Dickstein Cancer Treatment Center
White Plains, New York, 10601, United States
-
Duke Cancer Center Raleigh
Raleigh, North Carolina, 27609, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Eastern Maine Medical Center
Bangor, Maine, 04401, United States
-
Edwards Comprehensive Cancer Center
Huntington, West Virginia, 25701, United States
-
Emory Decatur Hospital
Decatur, Georgia, 30033, United States
-
Englewood Hospital and Medical Center
Englewood, New Jersey, 07631, United States
-
Ephrata Cancer Center
Ephrata, Pennsylvania, 17522, United States
-
Fairview Clinics and Surgery Center Maple Grove
Maple Grove, Minnesota, 55369, United States
-
Fairview Ridges Hospital
Burnsville, Minnesota, 55337, United States
-
Fairview Southdale Hospital
Edina, Minnesota, 55435, United States
-
FirstHealth of the Carolinas-Moore Regional Hospital
Pinehurst, North Carolina, 28374, United States
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
-
Geisinger Medical Oncology-Selinsgrove
Selinsgrove, Pennsylvania, 17870, United States
-
Genesys Hurley Cancer Institute
Flint, Michigan, 48503, United States
-
Gibbs Cancer Center-Gaffney
Gaffney, South Carolina, 29341, United States
-
Gibbs Cancer Center-Pelham
Greer, South Carolina, 29651, United States
-
Good Samaritan Hospital - Cincinnati
Cincinnati, Ohio, 45220, United States
-
Grandview Hospital
Dayton, Ohio, 45405, United States
-
Greater Baltimore Medical Center
Baltimore, Maryland, 21204, United States
-
Gundersen Lutheran Medical Center
La Crosse, Wisconsin, 54601, United States
-
Guthrie Medical Group PC-Robert Packer Hospital
Sayre, Pennsylvania, 18840, United States
-
Hartford Hospital
Hartford, Connecticut, 06102, United States
-
Helen F Graham Cancer Center
Newark, Delaware, 19713, United States
-
Henry Ford Cancer Institute-Downriver
Brownstown, Michigan, 48183, United States
-
Henry Ford Health Providence Southfield Hospital
Southfield, Michigan, 48075, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Henry Ford Macomb Hospital-Clinton Township
Clinton Township, Michigan, 48038, United States
-
Henry Ford West Bloomfield Hospital
West Bloomfield, Michigan, 48322, United States
-
Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, 44124, United States
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Houston Methodist Sugar Land Hospital
Sugar Land, Texas, 77479, United States
-
Hurley Medical Center
Flint, Michigan, 48503, United States
-
Illinois CancerCare-Bloomington
Bloomington, Illinois, 61704, United States
-
Illinois CancerCare-Canton
Canton, Illinois, 61520, United States
-
Illinois CancerCare-Carthage
Carthage, Illinois, 62321, United States
-
Illinois CancerCare-Eureka
Eureka, Illinois, 61530, United States
-
Illinois CancerCare-Galesburg
Galesburg, Illinois, 61401, United States
-
Illinois CancerCare-Kewanee Clinic
Kewanee, Illinois, 61443, United States
-
Illinois CancerCare-Macomb
Macomb, Illinois, 61455, United States
-
Illinois CancerCare-Ottawa Clinic
Ottawa, Illinois, 61350, United States
-
Illinois CancerCare-Pekin
Pekin, Illinois, 61554, United States
-
Illinois CancerCare-Peoria
Peoria, Illinois, 61615, United States
-
Illinois CancerCare-Peru
Peru, Illinois, 61354, United States
-
Illinois CancerCare-Princeton
Princeton, Illinois, 61356, United States
-
Intermountain Health Lutheran Hospital
Wheat Ridge, Colorado, 80401, United States
-
Intermountain Medical Center
Murray, Utah, 84107, United States
-
Iowa Methodist Medical Center
Des Moines, Iowa, 50309, United States
-
Iwate Medical University Hospital
Shiwa-gun, Iwate, 028-3695, Japan
-
Jefferson Abington Hospital
Abington, Pennsylvania, 19001, United States
-
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
John H Stroger Jr Hospital of Cook County
Chicago, Illinois, 60612, United States
-
Johns Hopkins University/Sidney Kimmel Cancer Center
Baltimore, Maryland, 21287, United States
-
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2, Canada
-
Kadlec Clinic Hematology and Oncology
Kennewick, Washington, 99336, United States
-
Kagoshima City Hospital
Kagoshima, Kagoshima-ken, 890-8760, Japan
-
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, 95051, United States
-
Kaiser Permanente Northwest
Portland, Oregon, 97227, United States
-
Kaiser Permanente Sacramento Medical Center
Sacramento, California, 95825, United States
-
Kaiser Permanente-Franklin
Denver, Colorado, 80205, United States
-
Kaiser Permanente-Lone Tree
Lone Tree, Colorado, 80124, United States
-
Kaiser Permanente-Oakland
Oakland, California, 94611, United States
-
Kaiser Permanente-Rock Creek
Lafayette, Colorado, 80026, United States
-
Kaiser Permanente-San Francisco
San Francisco, California, 94115, United States
-
Kaiser Permanente-Vallejo
Vallejo, California, 94589, United States
-
Kaiser Permanente-Walnut Creek
Walnut Creek, California, 94596, United States
-
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826, United States
-
Lafayette Family Cancer Center-EMMC
Brewer, Maine, 04412, United States
-
Lahey Clinic
Burlington, Massachusetts, 01805, United States
-
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States
-
Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York, 10016, United States
-
Legacy Good Samaritan Hospital and Medical Center
Portland, Oregon, 97210, United States
-
Legacy Meridian Park Hospital
Tualatin, Oregon, 97062, United States
-
Legacy Mount Hood Medical Center
Gresham, Oregon, 97030, United States
-
Legacy Salmon Creek Hospital
Vancouver, Washington, 98686, United States
-
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Savannah, Georgia, 31405, United States
-
Logan Health Medical Center
Kalispell, Montana, 59901, United States
-
London Regional Cancer Program
London, Ontario, N6A 4L6, Canada
-
MD Anderson Cancer Center at Cooper-Voorhees
Voorhees Township, New Jersey, 08043, United States
-
MaineHealth Maine Medical Center- Scarborough
Scarborough, Maine, 04074, United States
-
Marin Cancer Care Inc
Greenbrae, California, 94904, United States
-
Marshfield Clinic - Wisconsin Rapids Center
Wisconsin Rapids, Wisconsin, 54494, United States
-
Marshfield Clinic Cancer Center at Sacred Heart
Eau Claire, Wisconsin, 54701, United States
-
Marshfield Clinic-Chippewa Center
Chippewa Falls, Wisconsin, 54729, United States
-
Marshfield Clinic-Wausau Center
Wausau, Wisconsin, 54401, United States
-
Marshfield Medical Center - Ladysmith
Ladysmith, Wisconsin, 54848, United States
-
Marshfield Medical Center - Minocqua
Minocqua, Wisconsin, 54548, United States
-
Marshfield Medical Center - Weston
Weston, Wisconsin, 54476, United States
-
Marshfield Medical Center-Marshfield
Marshfield, Wisconsin, 54449, United States
-
Marshfield Medical Center-Rice Lake
Rice Lake, Wisconsin, 54868, United States
-
Marshfield Medical Center-River Region at Stevens Point
Stevens Point, Wisconsin, 54482, United States
-
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, 70809, United States
-
Mayo Clinic Health Systems-Mankato
Mankato, Minnesota, 56001, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
MedStar Franklin Square Medical Center/Weinberg Cancer Institute
Baltimore, Maryland, 21237, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Memorial Health University Medical Center
Savannah, Georgia, 31404, United States
-
Memorial Medical Center-Las Cruces
Las Cruces, New Mexico, 88011, United States
-
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Commack
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Nassau
Uniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
-
Mercy Cancer Center - Sacramento
Sacramento, California, 95816, United States
-
Mercy Cancer Center-West Lakes
Clive, Iowa, 50325, United States
-
Mercy Hospital
Coon Rapids, Minnesota, 55433, United States
-
Mercy Hospital Joplin
Joplin, Missouri, 64804, United States
-
Mercy Hospital Pittsburg
Pittsburg, Kansas, 66762, United States
-
Mercy Hospital Springfield
Springfield, Missouri, 65804, United States
-
Mercy Medical Center - Des Moines
Des Moines, Iowa, 50314, United States
-
Mercy Medical Center-West Lakes
West Des Moines, Iowa, 50266, United States
-
Mercy San Juan Medical Center
Carmichael, California, 95608, United States
-
Methodist Willowbrook Hospital
Houston, Texas, 77070, United States
-
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
-
Middlesex Hospital
Middletown, Connecticut, 06457, United States
-
Minnesota Oncology Hematology PA-Woodbury
Woodbury, Minnesota, 55125, United States
-
Montefiore Medical Center-Einstein Campus
The Bronx, New York, 10461, United States
-
Munson Medical Center
Traverse City, Michigan, 49684, United States
-
National Cancer Center Hospital
Tokyo, 104 0045, Japan
-
Nebraska Cancer Specialists/Oncology Hematology West PC
Grand Island, Nebraska, 68803, United States
-
Nebraska Methodist Hospital
Omaha, Nebraska, 68114, United States
-
NorthShore University HealthSystem-Evanston Hospital
Evanston, Illinois, 60201, United States
-
NorthShore University HealthSystem-Glenbrook Hospital
Glenview, Illinois, 60026, United States
-
NorthShore University HealthSystem-Highland Park Hospital
Highland Park, Illinois, 60035, United States
-
Northside Hospital
Atlanta, Georgia, 30342, United States
-
Northwestern Medicine Cancer Center Delnor
Geneva, Illinois, 60134, United States
-
Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois, 60555, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Norton Brownsboro Hospital and Medical Campus
Louisville, Kentucky, 40241, United States
-
Norton Hospital Pavilion and Medical Campus
Louisville, Kentucky, 40202, United States
-
Norton Suburban Hospital and Medical Campus
Louisville, Kentucky, 40207, United States
-
Novant Health New Hanover Regional Medical Center
Wilmington, North Carolina, 28401, United States
-
OSF Saint Francis Hospital and Medical Group
Escanaba, Michigan, 49829, United States
-
Ochsner Medical Center Jefferson
New Orleans, Louisiana, 70121, United States
-
Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, 74146, United States
-
Orion Cancer Care
Findlay, Ohio, 45840, United States
-
Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, K1H 8L6, Canada
-
PCR Oncology
Arroyo Grande, California, 93420, United States
-
Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, 93401, United States
-
Pacific Gynecology Specialists
Seattle, Washington, 98104, United States
-
Palo Alto Medical Foundation Health Care
Palo Alto, California, 94301, United States
-
Palo Alto Medical Foundation-Camino Division
Mountain View, California, 94040, United States
-
Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, 94040, United States
-
Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, 95065, United States
-
Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, 94086, United States
-
Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota, 55416, United States
-
Parkland Memorial Hospital
Dallas, Texas, 75235, United States
-
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, 80907, United States
-
Piedmont Hospital
Atlanta, Georgia, 30309, United States
-
Poudre Valley Hospital
Fort Collins, Colorado, 80524, United States
-
Prisma Health Cancer Institute - Faris
Greenville, South Carolina, 29605, United States
-
ProHealth D N Greenwald Center
Mukwonago, Wisconsin, 53149, United States
-
ProHealth Oconomowoc Memorial Hospital
Oconomowoc, Wisconsin, 53066, United States
-
ProHealth Waukesha Memorial Hospital
Waukesha, Wisconsin, 53188, United States
-
ProMedica Flower Hospital
Sylvania, Ohio, 43560, United States
-
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
Toledo, Ohio, 43606, United States
-
Providence Alaska Medical Center
Anchorage, Alaska, 99508, United States
-
Queen's Medical Center
Honolulu, Hawaii, 96813, United States
-
Rapid City Regional Hospital
Rapid City, South Dakota, 57701, United States
-
Reading Hospital
West Reading, Pennsylvania, 19611, United States
-
Regions Hospital
Saint Paul, Minnesota, 55101, United States
-
Riverside Methodist Hospital
Columbus, Ohio, 43214, United States
-
Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, 80012, United States
-
Rocky Mountain Cancer Centers-Littleton
Littleton, Colorado, 80120, United States
-
Rocky Mountain Cancer Centers-Rose
Denver, Colorado, 80220, United States
-
Rocky Mountain Cancer Centers-Sky Ridge
Lone Tree, Colorado, 80124, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
Rush MD Anderson Cancer Center
Chicago, Illinois, 60612, United States
-
Rush-Copley Medical Center
Aurora, Illinois, 60504, United States
-
SMC Center for Hematology Oncology Union
Union, South Carolina, 29379, United States
-
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, 83706, United States
-
Saint Charles Health System
Bend, Oregon, 97701, United States
-
Saint Dominic-Jackson Memorial Hospital
Jackson, Mississippi, 39216, United States
-
Saint Francis Cancer Center
Greenville, South Carolina, 29607, United States
-
Saint Francis Hospital
Greenville, South Carolina, 29601, United States
-
Saint Francis Medical Center
Cape Girardeau, Missouri, 63703, United States
-
Saint Francis Regional Medical Center
Shakopee, Minnesota, 55379, United States
-
Saint George Regional Medical Center
St. George, Utah, 84770, United States
-
Saint John's Hospital - Healtheast
Maplewood, Minnesota, 55109, United States
-
Saint Luke's Cancer Institute - Boise
Boise, Idaho, 83712, United States
-
Saint Luke's Cancer Institute - Fruitland
Fruitland, Idaho, 83619, United States
-
Saint Luke's Cancer Institute - Meridian
Meridian, Idaho, 83642, United States
-
Saint Luke's Cancer Institute - Nampa
Nampa, Idaho, 83687, United States
-
Saint Luke's University Hospital-Bethlehem Campus
Bethlehem, Pennsylvania, 18015, United States
-
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, 54301, United States
-
Saint Vincent Hospital Cancer Center at Marinette
Marinette, Wisconsin, 54143, United States
-
Saint Vincent Hospital Cancer Center at Oconto Falls
Oconto Falls, Wisconsin, 54154, United States
-
Saint Vincent Hospital Cancer Center at Saint Mary's
Green Bay, Wisconsin, 54303, United States
-
Saint Vincent Hospital Cancer Center at Sturgeon Bay
Sturgeon Bay, Wisconsin, 54235-1495, United States
-
Saitama Medical University International Medical Center
Saitama, 350-1298, Japan
-
Sanford Bismarck Medical Center
Bismarck, North Dakota, 58501, United States
-
Sanford Broadway Medical Center
Fargo, North Dakota, 58122, United States
-
Sanford Cancer Center Oncology Clinic
Sioux Falls, South Dakota, 57104, United States
-
Sanford Joe Lueken Cancer Center
Bemidji, Minnesota, 56601, United States
-
Sanford Roger Maris Cancer Center
Fargo, North Dakota, 58122, United States
-
Sanford USD Medical Center - Sioux Falls
Sioux Falls, South Dakota, 57117-5134, United States
-
Schoolcraft Memorial Hospital
Manistique, Michigan, 49854, United States
-
Seoul National University Hospital
Seoul, 110-744, South Korea
-
Sibley Memorial Hospital
Washington D.C., District of Columbia, 20016, United States
-
Skagit Regional Health Cancer Care Center
Mount Vernon, Washington, 98274, United States
-
Skagit Valley Hospital
Mount Vernon, Washington, 98274, United States
-
Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, 06105, United States
-
Smilow Cancer Hospital Care Center-Fairfield
Fairfield, Connecticut, 06824, United States
-
Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut, 06611, United States
-
Smilow Cancer Hospital-Torrington Care Center
Torrington, Connecticut, 06790, United States
-
South Carolina Cancer Specialists PC
Hilton Head Island, South Carolina, 29926-3827, United States
-
Southeastern Medical Oncology Center-Goldsboro
Goldsboro, North Carolina, 27534, United States
-
Southeastern Medical Oncology Center-Jacksonville
Jacksonville, North Carolina, 28546, United States
-
Southwest Gynecologic Oncology Associates Inc
Albuquerque, New Mexico, 87106, United States
-
Spartanburg Medical Center
Spartanburg, South Carolina, 29303, United States
-
Springfield Clinic
Springfield, Illinois, 62702, United States
-
Springfield Memorial Hospital
Springfield, Illinois, 62781, United States
-
State University of New York Downstate Medical Center
Brooklyn, New York, 11203, United States
-
Sudarshan K Sharma MD Limited-Gynecologic Oncology
Hinsdale, Illinois, 60521, United States
-
Summa Health System - Akron Campus
Akron, Ohio, 44304, United States
-
Sutter Medical Center Sacramento
Sacramento, California, 95816, United States
-
Sutter Pacific Medical Foundation
Santa Rosa, California, 95403, United States
-
Sutter Roseville Medical Center
Roseville, California, 95661, United States
-
Swedish Medical Center-First Hill
Seattle, Washington, 98122, United States
-
Texas Oncology - Central Austin Cancer Center
Austin, Texas, 78731, United States
-
Texas Oncology - Fort Worth Cancer Center
Fort Worth, Texas, 76104, United States
-
Texas Oncology - South Austin Cancer Center
Austin, Texas, 78745, United States
-
Texas Oncology Bedford
Bedford, Texas, 76022, United States
-
Texas Oncology-The Woodlands
The Woodlands, Texas, 77380, United States
-
The Cancer Institute Hospital Of JFCR
Koto-ku, Tokyo, 135-8550, Japan
-
The Hospital of Central Connecticut
New Britain, Connecticut, 06050, United States
-
The Mark H Zangmeister Center
Columbus, Ohio, 43219, United States
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
-
TidalHealth Nanticoke / Allen Cancer Center
Seaford, Delaware, 19973, United States
-
TriHealth Cancer Institute-Westside
Cincinnati, Ohio, 45247, United States
-
Trinity Cancer Care Center
Minot, North Dakota, 58701, United States
-
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Ann Arbor, Michigan, 48106, United States
-
Trinity Health Saint Joseph Mercy Oakland Hospital
Pontiac, Michigan, 48341, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
UC San Diego Moores Cancer Center
La Jolla, California, 92093, United States
-
UCHealth Memorial Hospital Central
Colorado Springs, Colorado, 80909, United States
-
UCHealth University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
UCSF Medical Center-Mission Bay
San Francisco, California, 94158, United States
-
UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital
Chicago, Illinois, 60657, United States
-
UF Health Cancer Institute - Gainesville
Gainesville, Florida, 32610, United States
-
UH Seidman Cancer Center at Lake Health Mentor Campus
Mentor, Ohio, 44060, United States
-
UHHS-Chagrin Highlands Medical Center
Beachwood, Ohio, 44122, United States
-
UHHS-Westlake Medical Center
Westlake, Ohio, 44145, United States
-
UI Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines, Iowa, 50309, United States
-
UI Health Care Mission Cancer and Blood - Laurel Clinic
Des Moines, Iowa, 50314, United States
-
UI Health Care Mission Cancer and Blood - West Des Moines Clinic
Clive, Iowa, 50325, United States
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
UPMC Susquehanna
Williamsport, Pennsylvania, 17701, United States
-
UT Southwestern/Simmons Cancer Center-Dallas
Dallas, Texas, 75390, United States
-
UW Cancer Center at ProHealth Care
Waukesha, Wisconsin, 53188, United States
-
United Hospital
Saint Paul, Minnesota, 55102, United States
-
University Cancer and Blood Center LLC
Athens, Georgia, 30607, United States
-
University Health Network-Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
-
University Hospitals Sharon Health Center
Wadsworth, Ohio, 44281, United States
-
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, 35233, United States
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
-
University of Cincinnati Cancer Center-UC Medical Center
Cincinnati, Ohio, 45219, United States
-
University of Iowa/Holden Comprehensive Cancer Center
Iowa City, Iowa, 52242, United States
-
University of Kansas Cancer Center
Kansas City, Kansas, 66160, United States
-
University of Kentucky/Markey Cancer Center
Lexington, Kentucky, 40536, United States
-
University of Maryland Shore Medical Center at Easton
Easton, Maryland, 21601, United States
-
University of Michigan Health - Sparrow Lansing
Lansing, Michigan, 48912, United States
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
-
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
University of New Mexico Cancer Center
Albuquerque, New Mexico, 87106, United States
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
-
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
-
University of Rochester
Rochester, New York, 14642, United States
-
University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, 36688, United States
-
University of Virginia Cancer Center
Charlottesville, Virginia, 22908, United States
-
University of Washington Medical Center - Montlake
Seattle, Washington, 98195, United States
-
University of Washington Medical Center - Northwest
Seattle, Washington, 98133, United States
-
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, 53792, United States
-
Utah Cancer Specialists-Salt Lake City
Salt Lake City, Utah, 84106, United States
-
VCU Massey Comprehensive Cancer Center
Richmond, Virginia, 23298, United States
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Weisberg Cancer Treatment Center
Farmington Hills, Michigan, 48334, United States
-
WellSpan Health-York Hospital
York, Pennsylvania, 17403, United States
-
Wellmont Holston Valley Hospital and Medical Center
Kingsport, Tennessee, 37660, United States
-
Wellmont Medical Associates Oncology and Hematology-Johnson City
Johnson City, Tennessee, 37604, United States
-
Wenatchee Valley Hospital and Clinics
Wenatchee, Washington, 98801, United States
-
Wentworth-Douglass Hospital
Dover, New Hampshire, 03820, United States
-
West Michigan Cancer Center
Kalamazoo, Michigan, 49007, United States
-
West Penn Hospital
Pittsburgh, Pennsylvania, 15224, United States
-
West Virginia University Charleston Division
Charleston, West Virginia, 25304, United States
-
Willamette Valley Cancer Center
Eugene, Oregon, 97401, United States
-
Woman's Hospital
Baton Rouge, Louisiana, 70817, United States
-
Women and Infants Hospital
Providence, Rhode Island, 02905, United States
-
Women's Cancer Care-Covington
Covington, Louisiana, 70433, United States
-
Women's Cancer Center of Nevada
Las Vegas, Nevada, 89106, United States
-
Women's Cancer Center of Seattle
Seattle, Washington, 98133, United States
-
Woodland Memorial Hospital
Woodland, California, 95695, United States
-
Wright-Patterson Medical Center
Wright-Patterson Air Force Base, Ohio, 45433, United States
-
Yale University
New Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo outsmart resistant breast and ovarian cancers?
- Can a pill target Hard-to-Treat ovarian cancers?
- Targeted pill aims to halt recurrent ovarian and endometrial cancers
- New hope for Platinum-Resistant ovarian cancer: ONC201 and paclitaxel combo trial launches
- Cancer drug combo tested for rare gene mutation – but trial stopped early
- Major trial tests if abdominal chemo beats IV for tough cancers